Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can mailed videos help close the kidney transplant gap?

NCT ID NCT03389932

First seen May 26, 2026 · Last updated Jun 19, 2026 · Updated 3 times

Summary

This study tested a home education program for nearly 1,000 people with chronic kidney disease. Participants received videos, postcards, and text messages about kidney transplant options. The goal was to see if this approach could increase knowledge about living and deceased donor transplants, especially among racial and ethnic minorities who often have less access to this information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Kaiser Permanente Research and Evaluation

    Pasadena, California, 91101, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

video and print transplant education modules with postcards and texting

What this could lead to

If successful, this approach could help more patients, especially minorities, make informed decisions about kidney transplants and potentially increase living donor transplants.

What could go wrong

This is an educational study, not a treatment trial. It may not directly change health outcomes, and knowledge gains may not lead to actual transplant increases.

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.